Intellipharmaceutics International Inc Asset Turnover Ratio (IPCIF), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Intellipharmaceutics International Inc   (IPCIF)
 

Intellipharmaceutics International Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Aug 31 2023, Intellipharmaceutics International Inc has not recorded any assets.
Visit Intellipharmaceutics International Inc Balance sheet

Within sector 6 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2023, to 210, from total ranking in the second quarter 2023 at 4209.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IPCIF Asset Turnover Ratio (Aug 31 2023)
III. Quarter		 (May 31 2023)
II. Quarter		 (Feb 28 2023)
I. Quarter		 (Nov 30 2022)
IV. Quarter		 0
III. Quarter
Y / Y Asset Change -2.62 % -2.65 % -32.69 % -2.84 % -6.31 %
Y / Y Revenue Change - - 291.25 % - -79.59 %
Asset Turnover Ratio (TTM) - 0.15 0.07 0.03 0.02
IPCIF's Total Ranking # 210 # 4209 # 0 # #
Seq. Asset Change -4.01 % 499.63 % -83.5 % 2.5 % -4.04 %
Seq. Revenue Change - 47.15 % 396.51 % 244.7 % -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 7
Healthcare Sector # 17
Overall Market # 210

Asset Turnover Ratio Statistics
High Average Low
109.18 44.13 1.04
(Nov 30 2022)   (Nov 30 2013)




IPCIF Company Profile • Back to IPCIF Efficiency Comparisons • Compare IPCIF Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Aug 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Aug 31 2023 Assets at quarter ending Aug 31 2023
Cue Health Inc   0.34 $ 198.915  Millions$ 579.823  Millions
Jazz Pharmaceuticals Plc  0.34 $ 3,794.392  Millions$ 11,086.746  Millions
Bausch and Lomb Corp  0.34 $ 3,969.000  Millions$ 11,674.000  Millions
United Therapeutics Corporation  0.34 $ 2,204.300  Millions$ 6,523.850  Millions
Nexgel Inc   0.34 $ 3.531  Millions$ 10.452  Millions
Invitae Corporation  0.34 $ 481.583  Millions$ 1,425.983  Millions
Provectus Biopharmaceuticals Inc   0.34 $ 0.601  Millions$ 1.784  Millions
Pfizer Inc  0.33 $ 68,537.000  Millions$ 207,002.750  Millions
Vanda Pharmaceuticals Inc   0.33 $ 211.851  Millions$ 640.517  Millions
Orthopediatrics Corp  0.33 $ 142.094  Millions$ 430.333  Millions
Amarin Corp Plcuk  0.33 $ 284.395  Millions$ 861.354  Millions
Pulmonx Corporation  0.33 $ 63.723  Millions$ 193.269  Millions
Comera Life Sciences Holdings Inc   0.33 $ 1.000  Millions$ 3.035  Millions
Bausch Health Companies Inc   0.33 $ 8,542.000  Millions$ 25,924.500  Millions
Prestige Consumer Healthcare Inc   0.33 $ 1,126.086  Millions$ 3,425.715  Millions
Cytomx Therapeutics Inc   0.33 $ 75.554  Millions$ 231.468  Millions
Mirum Pharmaceuticals Inc   0.33 $ 144.726  Millions$ 445.167  Millions
Amgen Inc   0.32 $ 26,833.000  Millions$ 83,661.000  Millions
Guardant Health Inc   0.32 $ 535.785  Millions$ 1,689.716  Millions
Regen Biopharma Inc   0.32 $ 0.127  Millions$ 0.401  Millions
Viatris Inc   0.31 $ 15,465.600  Millions$ 49,187.550  Millions
Apellis Pharmaceuticals Inc   0.31 $ 272.877  Millions$ 868.220  Millions
Yubo International Biotech Limited  0.31 $ 0.653  Millions$ 2.082  Millions
Aurinia Pharmaceuticals Inc   0.31 $ 158.853  Millions$ 506.634  Millions
Sotera Health Company  0.31 $ 989.752  Millions$ 3,160.830  Millions
Glaukos Corp  0.31 $ 303.063  Millions$ 970.087  Millions
Avid Bioservices Inc   0.31 $ 139.466  Millions$ 450.122  Millions
The Cooper Companies Inc   0.31 $ 3,592.900  Millions$ 11,597.000  Millions
Arrowhead Pharmaceuticals Inc   0.31 $ 240.735  Millions$ 786.164  Millions
Immunome Inc   0.30 $ 15.741  Millions$ 51.689  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.